LINTHICUM, Md., Oct. 17, 2005 (PRIMEZONE) -- Dialysis Corporation of America (Nasdaq:DCAI) announced that it has been ranked 17th in the newly issued Forbes list of "The 200 Best Small Companies". The list, which ranks companies with under $750M in sales, considers various long term trends such as growth, net profits, strength of management, and operating efficiencies.
Company President & CEO Stephen Everett said: "As our company continues to grow as a leading dialysis services provider, it is very gratifying to be recognized as one of the best companies of our size in the country. This is an exceptional achievement and we are very proud of our team of professionals that are responsible for the company's continued success."
Dialysis Corporation of America owns and operates freestanding kidney hemodialysis centers located in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, and Virginia, and provides in-hospital dialysis services on a contract basis to certain hospitals located in the those states. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis services.
This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, certain delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's facilities can expand to provide profitability, regulation of dialysis operations, government rate determination for Medicare reimbursement, and other risks detailed in the company's filings with the Securities and Exchange Commission, particularly as described in the company's proxy statement/prospectus relating to the merger of its parent, Medicore, Inc., with the company, and in its annual report on Form 10-K/A1 for the fiscal year ended December 31, 2004.
Other Dialysis Corporation of America press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the Securities and Exchange Commission are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.